The current VNDA market cap is 255.75M. The company's latest EPS is USD 0.0436 and P/E is 102.29.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 65.32M | 64.48M | 62.5M | 46.06M | 38.82M |
Operating Income | 3.91M | 6.63M | 2M | -2.87M | -6M |
Net Income | 3.27M | 6.86M | 3.25M | 1.52M | 137k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 227.19M | 248.17M | 268.68M | 254.38M | 192.64M |
Operating Income | 22.81M | 27.24M | 42.17M | 6.33M | -13.95M |
Net Income | 115.55M | 23.34M | 33.15M | 6.28M | 2.51M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 621.79M | 634.25M | 644.53M | 641.68M | 641.61M |
Total Liabilities | 106.13M | 107.05M | 108.79M | 101.78M | 98.51M |
Total Equity | 515.66M | 527.2M | 535.74M | 539.9M | 543.1M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 483.75M | 533.46M | 593.79M | 634.25M | 648.44M |
Total Liabilities | 72.8M | 80.19M | 88.86M | 107.05M | 103.53M |
Total Equity | 410.95M | 453.27M | 504.93M | 527.2M | 544.91M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 22.57M | 31.98M | 31.8M | 18.58M | 16.53M |
Investing | -25.5M | 49.93M | 187.29M | -3.6M | 31.73M |
Financing | 129k | 734k | N/A | N/A | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 45.95M | 51.78M | 64.21M | 31.98M | 12.8M |
Investing | -68.31M | -41.5M | -76.7M | 49.93M | -12.06M |
Financing | 6.26M | 5.63M | 3.55M | 734k | N/A |
Market Cap | 255.75M |
Price to Earnings Ratio | 102.29 |
Price to Sales Ratio | 1.33 |
Price to Cash Ratio | 1.89 |
Price to Book Ratio | 0.47 |
Dividend Yield | - |
Shares Outstanding | 57.54M |
Average Volume (1 week) | 2.25M |
Average Volume (1 Month) | 5.51M |
52 Week Change | -28.99% |
52 Week High | 7.00 |
52 Week Low | 3.295 |
Spread (Intraday) | 0.01 (0.22%) |
Company Name | Vanda Pharmaceuticals Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.vandapharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.